Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Significance of Ga-68 FAPI PET Before Immunotherapy in Pleural Mesothelioma

NCT06451536 is registered in ClinicalTrials.gov with Ankara University as lead sponsor.

NCT NCT06451536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06451536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Significance of Ga-68 FAPI PET Before Immunotherapy in Pleural Mesothelioma
Lead sponsor
Ankara University
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2024
Completion date
April 30, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mesotheliomas pleural